NEUROGENE INC (NGNE) Stock Earnings & Estimates
NASDAQ:NGNE - US64135M1053 - Common Stock
19.75 USD
+0.14 (+0.71%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 925K | -100.00% | 63.233M | 234.8M 271.33% | 619.45M 163.82% | 891.53M 43.92% | ||||||
| EBITDA YoY % growth | -57.536M 3.13% | -52.321M 9.06% | -79.31M -51.58% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -59.097M 2.64% | -55.583M 5.95% | -82.505M -48.44% | -114.569M -38.86% | -125.123M -9.21% | -145.401M -16.21% | -138.707M 4.60% | -103.994M 25.03% | 31.824M 130.60% | 377.45M 1,086.05% | 607.05M 60.83% | |
| Operating Margin | N/A | N/A | -8,919.46% | N/A | N/A | N/A | N/A | -164.46% | 13.55% | 60.93% | 68.09% | |
| EPS YoY % growth | -8.80 -300.70% | N/A 35.36% | -4.27 24.93% | -4.89 -14.45% | -5.23 -6.94% | -5.80 -10.92% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.28 -7.14% | -1.39 -40.64% | -1.51 -39.78% | -1.56 -48.87% | -1.63 -27.80% | -1.65 -18.68% | -1.54 -2.03% | -1.58 -1.14% | -1.62 0.47% | -1.66 -0.62% |
| Revenue Q2Q % growth | ||||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.468M -32.86% | -32.599M -51.54% | -29.58M -29.27% | -30.116M -10.75% | -30.651M -4.02% | -31.187M 4.33% | -33.915M -14.66% | -34.68M -15.16% | -35.445M -15.64% | -36.21M -16.11% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.05 3.67% | -1.18 | 0.13 | 11.15% |
| Q1 2025 Q2Q % growth | -1.08 -8.00% | -1.08 | 0.00 | 0.42% |
| Q4 2024 Q2Q % growth | -0.99 34.44% | -1.15 | 0.16 | 14.11% |
| Q3 2024 Q2Q % growth | -1.19 -190.24% | -1.25 | 0.06 | 4.50% |
| Q2 2024 Q2Q % growth | -1.09 -2,571.57% | -1.07 | -0.02 | -1.77% |
| Q1 2024 Q2Q % growth | -1.00 80.47% | -1.16 | 0.16 | 13.62% |
| Q4 2023 Q2Q % growth | -1.51 68.54% | -1.20 | -0.31 | -26.17% |
| Q3 2023 Q2Q % growth | -0.41 65.83% | -0.03 | -0.38 | -1,239.87% |
| Q2 2023 Q2Q % growth | 97.09% | -0.04 | % | |
| Q1 2023 Q2Q % growth | -5.12 -265.71% | -2.55 | -2.57 | -100.78% |
| Q4 2022 Q2Q % growth | -4.80 -248.80% | -3.88 | -0.92 | -23.84% |
| Q3 2022 Q2Q % growth | -1.20 -328.57% | -1.55 | 0.35 | 22.67% |
| Q2 2022 Q2Q % growth | -1.40 -418.52% | -1.53 | 0.13 | 8.50% |
| Q1 2022 Q2Q % growth | -1.40 -418.52% | -1.51 | 0.11 | 7.47% |
| Q4 2021 Q2Q % growth | -1.38 -473.40% | -1.51 | 0.13 | 8.75% |
| Q3 2021 Q2Q % growth | -0.28 -47.37% | -0.28 | 0.00 | 1.37% |
| Q2 2021 Q2Q % growth | -0.27 -35.00% | -0.27 | 0.00 | -1.03% |
| Q1 2021 Q2Q % growth | -0.27 -50.00% | -0.23 | -0.04 | -16.10% |
| Q4 2020 Q2Q % growth | -0.24 -9.09% | -0.26 | 0.02 | 6.51% |
| Q3 2020 Q2Q % growth | -0.19 56.82% | -0.22 | 0.03 | 15.33% |
| Q2 2020 Q2Q % growth | -0.20 | -0.21 | 0.01 | 6.63% |
| Q1 2020 Q2Q % growth | -0.18 -100.00% | -0.24 | 0.06 | 25.22% |
| Q4 2019 Q2Q % growth | -0.22 | -0.38 | 0.16 | 41.71% |
| Q3 2019 Q2Q % growth | -0.44 | -0.04 | -0.40 | -978.43% |
| Q2 2019 Q2Q % growth | 0.00 | -0.05 | 0.05 | 100.00% |
| Q1 2019 Q2Q % growth | -0.09 | -0.23 | 0.14 | 61.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -4.38% |
| Revenue | N/A | N/A | N/A | N/A |